Singh, GKDas, PSrivastava, SSingh, KSingh, VBarui, SMulajkar, DDubey, IP.2025-06-182025-06-182025-04Singh GK, Das P, Srivastava S, Singh K, Singh V, Barui S, Mulajkar D, Dubey IP.. Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment. Indian Journal of Dermatology, Venereology and Leprology. 2025 Apr; 91(2): 180-1870378-63230973-3922https://imsear.searo.who.int/handle/123456789/249390Cutaneous T-cell lymphoma is a heterogeneous group of T-cell neoplasms, of which mycosis fungoides and Sezary syndrome are the most common. The prognosis depends on the stage of the disease. The early stage follows a protracted course with a five-year disease-specific survival of greater than 95% and is treated with skin-directed topical therapies, phototherapy, and oral drugs like methotrexate. Advanced disease has a five-year overall survival of less than 25% and requires management by systemic chemotherapeutic agents. This review article is the second part out of the two covering the staging, prognosis, and treatment from a dermatologist’s perspective.Mycosis fungoidesSezary syndromeCTCLcutaneous T cell lymphomaMycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatmentJournal ArticleIndiaDepartment of Dermatology, Bharati Vidyapeeth’s Medical College, Pune, IndiaDepartment of Dermatology, Armed Forces Medical College, Pune, IndiaDepartment of Dermatology, Base Hospital Delhi Cantonment and Army College of Medical Sciences Delhi Cantt, IndiaDepartment of Pathology, Army Hospital, Research and Referral Kolkata, IndiaDepartment of Pathology, Armed Forces Medical College, Pune, IndiaDepartment of Pathology, Base Hospital, Delhi Cantonment and Army College of Medical Sciences, Delhi Cantt, IndiaDepartment of Medical Oncology, Army Hospital Research and Referral, Delhi, IndiaDepartment of Nuclear Imaging, Army Hospital Research and Referral, Delhi, India.